Skip to main content
. 2024 Aug 19;10(3):e004395. doi: 10.1136/rmdopen-2024-004395

Figure 2. For the incident Southeast Norway SLE cohort during 2000–2017, at time of diagnosis: (A) Distribution of age and sex for cases with a confirmed diagnosis. (B) Estimated percentage of cases with a confirmed SLE diagnosis fulfilling the 2019 EULAR/ACR classification criteria for SLE and the 1997 ACR classification criteria for SLE. (C) Mean and actual number of classification points for all cases fulfilling the 2019 EULAR/ACR classification criteria. (D) Calculated number of classification points for the ANA-positive and ANA-negative subsets of SLE cases not classifiable via the 2019 EULAR/ACR criteria. ACR, American College of Rheumatology; ANA, antinuclear antibodies; EULAR, European Alliance of Associations for Rheumatology; SLE, systemic lupus erythematosus.

Figure 2